Known active viral or nonviral hepatitis or cirrhosis
Active or chronic viral hepatitis B or C infection
Active hepatitis B viral infection (defined as HBsAg+).
Participants with hepatitis B should be on appropriate anti-viral therapy at the time of the transplant, and their viral load should be negative; timeline: within 3 weeks prior to enrollment
Patients with cirrhosis, or active viral or nonviral hepatitis
Patients with known (testing is not part of the protocol) active hepatic disease (i.e., hepatitis B or C) due to risk of drug interactions with anti-viral therapy
Active hepatitis viral infections
HIV or hepatitis C - presence of viral load
Patients with cirrhosis, or active viral or nonviral hepatitis
Patients with active viral hepatitis.
Active or symptomatic viral hepatitis or chronic liver disease
Active or chronic viral hepatitis B or C infection Exclusions Related to Ocular Disease
Known active hepatitis, type B or C; patients on suppressive therapy with a negative viral load and no evidence of hepatic damage are eligible
Active or symptomatic viral hepatitis or chronic liver disease
Active or symptomatic viral hepatitis or chronic liver disease.
Active or symptomatic viral hepatitis or chronic liver disease.
Subjects with known HIV or active viral hepatitis
Known active viral or nonviral hepatitis or cirrhosis
Active liver disease, including viral or other hepatitis, or cirrhosis
Active hepatitis B. Patients with chronic hepatitis B who are on appropriate viral suppressive therapy may be allowed after discussion with the principal investigator (PI).
Active viral hepatitis A, B, or C or preexisting or acute liver disease;
Chronic active or active viral hepatitis A, B, or C infection
Known active viral hepatitis, HIV or chronic liver disease.
Active or symptomatic viral hepatitis or chronic liver disease
Known active or symptomatic viral hepatitis or chronic liver disease
Active hepatitis, including but not limited to viral and drug-induced
Active or symptomatic viral hepatitis or chronic liver disease
Active or symptomatic viral hepatitis or chronic liver disease
Known active viral or other chronic types hepatitides (hepatitis B, C) or cirrhosis
Known active viral or nonviral hepatitis or cirrhosis
Patients with hepatitis B and/or hepatitis C infection are excluded if they are on any of the following viral suppressive agents: boceprevir (Victrelis), ribavirin (Rebetol, Ribatab, Ribasphere), telaprevir (Incivek)\r\n* Note: patients with active hepatitis B infection must be on treatment with viral suppressive therapies; these agents may include the following: adefovir (Hepsera), entecavir (Baraclude), lamivudine (Epivir-HBV), telbivudine (Tyzeka), and/or tenofovir (Viread)
Active liver disease (i.e., cirrhosis, viral or autoimmune hepatitis, etc.)
Patients with cirrhosis, or active viral or non-viral hepatitis
Patients with a history of hepatitis C, but have a negative viral load, are eligible
Patients with PRIMARY HEPATIC CANCER must have an undetectable viral load for Hepatitis B and C.
Known acute viral hepatitis
Active viral hepatitis.
Active symptomatic viral hepatitis or chronic liver disease
DONOR: Evidence of active infection or viral hepatitis
DONOR: Evidence of active infection or viral hepatitis
Known active viral or nonviral hepatitis or cirrhosis
Active viral hepatitis, active human immunodeficiency virus (HIV) or chronic liver disease.
Known active viral or nonviral hepatitis or cirrhosis
Known active or chronic viral hepatitis or history of any type of hepatitis within the last 6 months
Any chronic or concurrent acute liver disease, including viral hepatitis
Active/uncontrolled viral hepatitis
History of, or presently active or chronic viral infections (i.e. zoster or hepatitis)
Active viral hepatitis
Active or symptomatic viral hepatitis or chronic liver disease
A diagnosis of active hepatitis B or C as defined by detectable viral load assays in the blood
Known active or chronic viral hepatitis or history of any type of hepatitis within the last 6 months.
Active or symptomatic viral hepatitis or chronic liver disease
Active or symptomatic viral hepatitis or chronic liver disease
Known active viral infection\r\n* Note: viral hepatitis testing is required at screening for all patients
Active or symptomatic viral hepatitis
Severe active viral infection, especially hepatitis B.
Active liver disease, including viral or other hepatitis, or cirrhosis
Known acute viral hepatitis
Patients with active viral hepatitis
Active or chronic viral hepatitis or history of any type of hepatitis within the last 6 months
Active viral hepatitis
Active or symptomatic viral hepatitis or chronic liver disease
Active or symptomatic viral hepatitis or chronic liver disease
Active or symptomatic viral hepatitis or chronic liver disease, including Child-Pugh class B and C liver disease
Active or symptomatic viral hepatitis or chronic liver disease
Active or symptomatic viral hepatitis or chronic liver disease
Active hepatitis B or C viral infection
Participants who are known to have active hepatitis A, B, or C viral infection may not participate in this study; active disease is defined as participants with a known viral hepatitis whose liver function tests are elevated beyond the criteria indicated
Known or active HIV, viral hepatitis B or C
DONOR: Evidence of active infection or viral hepatitis
Active or uncontrolled clinically serious infection. (Participants with chronic viral hepatitis are eligible.)
Active or symptomatic viral hepatitis or chronic liver disease
Subject has known active liver disease, including viral hepatitis or cirrhosis.
Active or symptomatic viral hepatitis or chronic liver disease
Known active viral or nonviral hepatitis